Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $1.33 is 22.02% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 1.35||$ 4.992|
|Low:||$ 1.33||$ 1.09|
Company Description (as filed with the SEC)
We are a biopharmaceutical company developing approaches to activate and co-stimulate a patient's immune system against cancer. Our co-stimulatory antibody is designed to harness the body's natural antigen specific immune activation and tolerance mechanisms to reprogram the immunity and provide a long-term, durable clinical effect. Our T-cell activating platform (TCAP) produces therapies designed to turn immunologically "cold" tumors "hot," and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Unlike many other "patient specific" immunotherapy approaches, our drugs are "off-the-shelf" which means that we can administer drug immediately without extracting patient material at a substantially lower cost of goods sold. Our TCAP product candidates from our ImPACT® and ComPACT(TM) platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. ... More ...
Nasdaq Official Price
Dec. 7, 2018
Dec. 7, 2018